BGMS (Bio Green Med Solution, Inc.) Stock Financials & Earnings

BGMSBio Green Med Solution, Inc.

Mkt Cap$2M

Revenue (TTM)$81,000

Net Income (TTM)-$5M

EPS (TTM)-$81.44

Free Cash Flow (TTM)-$6M

Gross Margin18.5%

Op. Margin-11324.7%

Net Margin-6714.8%

FCF Margin-7522.2%

P/S Ratio (TTM)22.4x

P/E Ratio (TTM)—

YoY Rev Growth+9.5%

Employees—

Earnings Reports

Next: Q4 2025 · Apr 1

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$5M	-$9M
Q1 23	$0	-$8K	-$7M
Q2 23	$373K	$373K	-$6M
Q3 23	$16K	$16K	-$6M
Q4 23	$31K	$23K	-$6M
Q1 24	$29K	$27K	-$7M
Q2 24	$4K	$4K	-$4M
Q3 24	$10K	$10K	-$2M
Q4 24	$0	-$1K	-$2M
Q1 25	$0	$0	-$5M
Q2 25	$0	-$1K	-$1M
Q3 25	$81K	$17K	-$992K

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 22	$7M	$2M	—
Q1 23	$6M	$2M	$18K
Q2 23	$5M	$2M	—
Q3 23	$5M	$2M	—
Q4 23	$4M	$2M	—
Q1 24	$6M	$2M	—
Q2 24	$2M	$2M	—
Q3 24	$950K	$1M	—
Q4 24	$880K	$948K	—
Q1 25	$822K	$4M	—
Q2 25	$67K	$1M	—
Q3 25	$5K	$1M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$18M	$0	$18M
Q1 23	$11M	$0	$11M
Q2 23	$10M	$0	$10M
Q3 23	$6M	$0	$6M
Q4 23	$3M	$0	$3M
Q1 24	$3M	$0	$3M
Q2 24	$6M	$0	$6M
Q3 24	$3M	$0	$3M
Q4 24	$3M	$0	$3M
Q1 25	$3M	$0	$3M
Q2 25	$4M	$0	$4M
Q3 25	$4M	$0	$4M

Shares Outstanding